Osteoporosis – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of osteoporosis comprises epidemiological estimates of key patient populations in 45 countries worldwide.
Most patient populations are forecast over a period of 20 years for the mature markets and Europe and 10 years for the other countries we cover.
All forecast data are available on Clarivate’s Insights Platform in tabular format, with options to download to osteoporosis Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Clarivate Epidemiology’s osteoporosis forecast answers the following questions:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of osteoporosis over the forecast period?
- How will changes in the levels of exposure to known risk or protective factors affect the number of people at high risk for hip fracture (HF) or a major osteoporotic fracture (MOF)?
- Of all people with osteoporosis, how many in each of the major mature pharmaceutical markets have been formally diagnosed?
- Of all people diagnosed with osteoporosis, how many in each of the major mature pharmaceutical markets are drug-treated?
In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least 10 years of forecast data for the following osteoporosis subpopulations for mature markets:
- Diagnosed prevalent cases
- Drug-treated prevalent cases
Note: Coverage may vary by country.
